Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.
Astrocyte Pharmaceuticals has raised $400K in total funding. The most recent round was Grant. The last funding was announced in August 2026.
Astrocyte Pharmaceuticals's investors include DeepWork Capital, Navis Capital Partners, National Institutes of Health, Alzheimer's Drug Discovery Foundation, Kaitai Capital.
Astrocyte Pharmaceuticals is headquartered in Cambridge, United States.
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.
Astrocyte Pharmaceuticals is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Astrocyte Pharmaceuticals — Funding & Investors." VCBacked, August 25, 2026, https://www.vcbacked.co/company/astrocyte-pharmaceuticals. Accessed September 3, 2026.
VCBacked. (2026). Astrocyte Pharmaceuticals — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/astrocyte-pharmaceuticals
{{cite web |title=Astrocyte Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/astrocyte-pharmaceuticals |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated